Stock Market Today: GIFT Nifty on the NSE IX increased by 55 points to nearby 22,505.50 on Monday, indicating that Dalal Street was off to a good start. “Nifty closed above the crucial resistance zone of 22,250-300 levels on weekly closing basis and we believe that as long as Nifty is holding above 22,000 mark, the rally is likely to continue and it can test the next resistance zone of 22,450-500 on an immediate basis and eventually Nifty can test level of 22,700 on the higher side,” Tejas Shah, the Technical Research Analyst at JM Financial and Blink stated. On Friday, the rupee fell 2 paise to settle at 82.91 against the US dollar as the price of crude oil increased on the international market.
Stock Market Today: Stocks in focus
Signature Global
The real estate company Signature Global declared on Sunday that it had sold more than 1,000 units in its opulent Gurugram project, bringing in over Rs 3,600 crore. The strong demand for residential real estate, especially in the luxury market, is credited with this achievement. The business revealed in a regulatory filing that pre-launch sales for its most recent premium residential development project, “DE LUXE-DXP,” situated in Gurugram’s Sector 37D, exceeded Rs 3,600 crore.
Coal India
According to Businessline on Saturday, Coal India officials expressed confidence in reaching their 780 million tonnes output target for the fiscal year 2023–2024. This claim is especially significant in view of recent media rumours indicating that the coal mining company would miss its goal by 10 million tonnes. At a stakeholders’ meeting, corporate executives emphasised that earlier statements regarding possibly missing the target had been misconstrued. The purpose of the gathering was to notify producers of mining equipment about the increased demand for their products.
Lupin
In the upcoming year, Lupin Digital Health (LDH), a platform that specialises in digital therapies for cardiac rehabilitation, hopes to grow its clientele by a factor of ten. As the company expands into more locations and forms partnerships with more institutions, this growth is anticipated, according to Sidharth Srinivasan, CEO of Lupin Digital Health, in a Mint interview. “We showed that digital therapeutics can significantly improve patient outcomes, even for those with serious cardiac conditions, in the Indian context,” Srinivasan continued after the platform’s testing phase.
Disclaimer: (This information is provided solely for informational purposes. It is important to note that investing in the market or a business idea involves market risks. Before investing money as an investor/ owner/ partner, always consult an expert. DNP News Network Private Limited never advises to invest money on stocks or any specific business idea. We will not be liable for any financial losses.)
Keep watching our YouTube Channel ‘DNP INDIA’. Also, please subscribe and follow us on FACEBOOK, INSTAGRAM, and TWITTER
